MO, KS helping families in need pay for groceries this summer for kids
SHAWNEE, Kan. — Parents who are struggling to pay the bills and have school-age children could be eligible for SUN Bucks this summer.
SUN Bucks stands for Summer Electronic Benefits Transfer.
It's a federal program for low-income parents to receive a one-time payment of $120 per child to help pay for groceries during the summer months.
Kansas City's Country Club Plaza struggles with closures and empty shops
Most metro schools are already offering free breakfast and lunch during the summer, so SUN Bucks can be used to help pay for dinners.
There are no income requirements for the free lunch program at area schools. All kids are welcome to get a free meal. Parents are encouraged to reach out to their school district to find out where kids can go to eat breakfast and lunch for free.
As for SUN Bucks, this is the second year of the federal program.
More than 125,000 kids in Kansas received the $120 subsidy last summer. More than 490,000 kids in Missouri are expected to get SUN Bucks this summer.
Last year, Missouri didn't get the SUN Bucks out until September due to technical and staffing issues. But they are ready this summer and started sending out these benefits last week.
This program is for families that are struggling financially.
If you receive SNAP benefits for groceries, or if your child gets a free or reduced-price meal at school, the $120 per child will automatically be sent to you or added to your SNAP card. However, you must spend that money by the end of September, or you will lose it.
For those who didn't get the money added to their SNAP card, or for those who think they are eligible and want to apply, that information can be found online for Missouri residents and Kan. All but 12 states participate in the SUN Bucks program.
As for the free lunch program during the summer, school districts are only serving food at certain schools through the end of July.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory
We came across a bullish thesis on ClearPoint Neuro, Inc. (CLPT) on M.V. Cunha's Substack. In this article, we will summarize the bulls' thesis on CLPT. ClearPoint Neuro, Inc. (CLPT)'s share was trading at $13.93 as of 6th June. A medical doctor surrounded by advanced technology in the operating room. ClearPoint Neuro is transforming from a surgical tools provider into a critical platform company enabling the next generation of neurological treatments. In the first quarter of 2025, revenue grew 31 percent year-over-year to 8.5 million dollars, led by the rapid adoption of its SmartFrame operating room system, which increased 70 percent and allows hospitals to use ClearPoint technology in standard surgical settings. This expansion seeds a larger installed base and drives high-margin recurring revenue from disposable instruments. The biologics and drug delivery segment generated 4.7 million dollars in revenue, growing 9 percent year-over-year, and is supported by more than 60 active partnerships with gene and cell therapy developers. As these therapies move toward commercial use, ClearPoint's role as the enabling delivery infrastructure could become its most profitable revenue stream, with each procedure generating over 20,000 dollars in high-margin recurring revenue. Meanwhile, the company is intentionally moving away from capital equipment sales, which declined 63 percent, in favor of a subscription-based model that provides predictable recurring revenue. Operating cash burn fell 35 percent in 2024, with expenses rising 29 percent in the latest quarter due to targeted investments in preclinical services, therapy support, and device innovation. ClearPoint closed the quarter with 12.4 million dollars in cash and access to up to 105 million dollars in financing, providing sufficient capital to reach financial breakeven without near-term equity dilution. While risks around execution, partner dependency, and regulatory pacing remain, ClearPoint's embedded position across neurological therapy development offers investors a unique opportunity to benefit from a long-term transformation into the backbone of next-generation brain treatments. Previously, we highlighted a on ClearPoint Neuro from northeasternsvf in January 2025, which emphasized its unique position as the only FDA-cleared, MRI-guided neurosurgical platform enabling precise delivery of CNS gene and cell therapies. That thesis focused on the company's expanding biopharma partnerships, operating room penetration through SmartFrame OR, and its path to profitability via high-margin disposables. ClearPoint Neuro, Inc. (CLPT) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 21 hedge fund portfolios held CLPT at the end of the first quarter which was 13 in the previous quarter. While we acknowledge the risk and potential of CLPT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than CLPT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.
Yahoo
16 minutes ago
- Yahoo
DocuSign, Inc. (DOCU): A Bear Case Theory
We came across a bearish thesis on DocuSign, Inc. (DOCU) on Deep Value Returns' Substack. In this article, we will summarize the bears' thesis on DOCU. DocuSign, Inc. (DOCU)'s share was trading at $75.28 as of 6th June. DOCU's trailing and forward P/E were 14.31 and 20.07 respectively according to Yahoo Finance. A close-up of a laptop displaying loan documents, representing the company's residential mortgage guaranty insurance and mortgage loans. DocuSign (DOCU) saw its stock fall nearly 17% to around $77 following a disappointing fiscal 2026 outlook, which revised expected billings growth from 9% to 7% year-over-year. This was a significant setback for what had been a slow turnaround story, with billings being a key leading indicator of future revenue. The updated guidance casts doubt on the company's ability to reaccelerate growth, suggesting revenue may trend from 8% to as low as 5% y/y through the remainder of the year. Compounding concerns, DocuSign's free cash flow margins—a core pillar of the bull thesis—fell to 29.8% in Q1 from 32.7% a year earlier, prompting a downward revision of full-year margin expectations from 33% to 31%. While DocuSign still boasts a strong balance sheet with no debt and roughly $950 million in cash (about 6% of its market cap), the business is now expected to generate just $985 million in free cash flow, implying a 16x forward multiple for a company facing marginal growth. This valuation is no longer attractive in light of eroding operating leverage. The author, previously optimistic due to the company's margin potential and balance sheet strength, now views the risk/reward as balanced at best. With both billings and free cash flow coming in below even conservative expectations, the original thesis has broken down. As such, the author's position has been closed, with capital redirected toward opportunities offering stronger growth visibility and cleaner execution setups. This candid reassessment reflects a disciplined exit rather than emotional capitulation. Previously, we summarized a standout on Super Micro Computer by the same author, emphasizing its strategic alignment with AI infrastructure demand, scalable custom server offerings, and attractive free cash flow valuation, arguing that current headwinds are transitory and already priced in. DocuSign, Inc. (DOCU) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 41 hedge fund portfolios held DOCU at the end of the first quarter which was 51 in the previous quarter. While we acknowledge the risk and potential of DOCU as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
KiWear Unveils Smart Ring Input Solution for AI Glasses in Collaboration with Qualcomm at AWE USA 2025
Collaboration addresses interactive solutions for smart glasses as global smart glasses shipments surge 210%i year-over-year LONG BEACH, Calif., June 10, 2025--(BUSINESS WIRE)--KiWear, Inc. today announced a reference design for a smart ring input solution for use with smart glasses and AI glasses during Qualcomm Technologies, Inc.'s opening keynote presentation at AWE USA 2025. The collaboration aims to help OEMs develop interactive solutions for AI smart glass partners. Industry analysts expect 60% year-over-year growth in 2025 and a sustained CAGR of over 60% through 2029. "Qualcomm Technologies is fueling the AI glasses industry with our Snapdragon® XR Platforms. KiWear's smart ring, featuring algorithms co-developed with Qualcomm Technologies, makes an ideal input device for smart glasses and AI glasses," said Ziad Asghar, SVP & GM of XR at Qualcomm Technologies, Inc. "This new reference design represents a step forward in helping OEMs to deliver solutions that enable intuitive and discreet gesture based interaction for the growing category of AI smart glasses. "We are thrilled to build next generation input solutions for both AI and XR together with industry leaders such as Qualcomm," said Chris Shi, Founder and CEO of KiWear, Inc. Leading HCI Innovation KiWear, recognized as a leader in HCI innovations, has developed cutting-edge smart ring technology that enables seamless hand-centric interactions with smart glasses and AI glasses. The company's solutions address fundamental input challenges that have limited widespread smart glasses adoption. Founded in April 2025, KiWear is a Delaware-based company delivering comprehensive HCI solutions for multi-DoF controllers, smart rings, and wearables. The company brings together prominent computer vision scientists, AI/XR integration experts, and hardware/software innovators, with expertise spanning conceptualization to mass production. KiWear has forged collaborations and delivers exclusive solutions to six of the global top 10 consumer electronics leaders. With R&D hubs in Shanghai and Beijing beyond its U.S. headquarters, the company partners with premier technology conglomerates to enable natural HCI solutions for next-generation XR and AI products. Live Demonstrations Conference attendees can experience KiWear's smart ring and watch technologies at the Qualcomm Technologies' booth (Booth 209) during AWE USA, showcasing seamless integration with smart glasses platforms. Snapdragon is a trademark or registered trademark of Qualcomm Incorporated. Snapdragon branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries. __________________________ i Source: View source version on Contacts Media Contact:Sally GaoKiWear +86-13918187350
